Skip to main content
. 2012 Nov 30;6:1987–1996. doi: 10.2147/OPTH.S35715

Figure 2.

Figure 2

Bacterial eradication and clinical resolution at each follow-up visit for patients with Pseudomonas aeruginosa infections at baseline treated with besifloxacin ophthalmic suspension 0.6%.